Literature DB >> 27073539

FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells.

Zhe Zhang1, Guojun Zhang2, Chuize Kong1.   

Abstract

The regulation of entry into and progression through mitosis is important for cell proliferation. Polo-like kinase 1 (PLK1) is involved in multiple stages of mitosis. Forkhead box protein M1 (FOXM1) has multiple functions in tumorigenesis and, in elevated levels, is frequently associated with cancer progression. The present study reports that FOXM1, a substrate of PLK1, controls the transcription mechanism that mediates the PLK1-dependent regulation of the cell cycle. The present study investigated the expression of PLK1 and FOXM1 in the clear renal cell carcinoma 769-P and ACHN cell lines, and indicated that the expression of PLK1 and FOXM1 are correlated in human renal cell cancer cell lines and that the suppression of PLK1 may decrease the expression of FOXM1. The knockdown of FOXM1 or PLK1 in renal cell cancer cell lines caused cell cycle progression to be blocked. As a result, the present study indicated the involvement of FOXM1 in PLK1-regulated cell cycle progression.

Entities:  

Keywords:  cell cycle; cell proliferation; forkhead box protein M1; polo-like kinase 1; renal cancer

Year:  2016        PMID: 27073539      PMCID: PMC4812172          DOI: 10.3892/ol.2016.4228

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Differential expression of forkhead box transcription factors following butylated hydroxytoluene lung injury.

Authors:  V V Kalinichenko; L Lim; B Shin; R H Costa
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-04       Impact factor: 5.464

2.  miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer.

Authors:  Xu-Ri Li; Hui-Jun Chu; Teng Lv; Lei Wang; Shou-Fang Kong; Shu-Zhen Dai
Journal:  FEBS Lett       Date:  2014-07-24       Impact factor: 4.124

3.  Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma.

Authors:  J A Pezuk; M S Brassesco; A G Morales; J C de Oliveira; R G de Paula Queiroz; H R Machado; C G Carlotti; L Neder; C A Scrideli; L G Tone
Journal:  Cancer Gene Ther       Date:  2013-07-26       Impact factor: 5.987

4.  High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.

Authors:  Zhe Zhang; Guojun Zhang; Chuize Kong
Journal:  Urol Oncol       Date:  2011-12-20       Impact factor: 3.498

5.  Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.

Authors:  Guojun Zhang; Zhe Zhang; Zhuogang Liu
Journal:  Tumour Biol       Date:  2013-03-14

6.  Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice.

Authors:  Valentina M Factor; Daekwan Seo; Tsuyoshi Ishikawa; Pal Kaposi-Novak; Jens U Marquardt; Jesper B Andersen; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

7.  PCM1 recruits Plk1 to the pericentriolar matrix to promote primary cilia disassembly before mitotic entry.

Authors:  Gang Wang; Qiang Chen; Xiaoyan Zhang; Boyan Zhang; Xiaolong Zhuo; Junjun Liu; Qing Jiang; Chuanmao Zhang
Journal:  J Cell Sci       Date:  2013-01-23       Impact factor: 5.285

8.  The expression of Nek7, FoxM1, and Plk1 in gallbladder cancer and their relationships to clinicopathologic features and survival.

Authors:  R Wang; Y Song; X Xu; Q Wu; C Liu
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

9.  High-risk human papillomavirus infection in different histological subtypes of renal cell carcinoma.

Authors:  Ali Farhadi; Abbas Behzad-Behbahani; Bita Geramizadeh; Zamberi Sekawi; Marjan Rahsaz; Sedigheh Sharifzadeh
Journal:  J Med Virol       Date:  2014-04-02       Impact factor: 2.327

10.  Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition.

Authors:  Michael V Gormally; Thomas S Dexheimer; Giovanni Marsico; Deborah A Sanders; Christopher Lowe; Dijana Matak-Vinković; Sam Michael; Ajit Jadhav; Ganesha Rai; David J Maloney; Anton Simeonov; Shankar Balasubramanian
Journal:  Nat Commun       Date:  2014-11-12       Impact factor: 14.919

View more
  17 in total

Review 1.  Targeting forkhead box M1 transcription factor in breast cancer.

Authors:  Ruth M O'Regan; Rita Nahta
Journal:  Biochem Pharmacol       Date:  2018-05-31       Impact factor: 5.858

2.  PLK1 promotes epithelial-mesenchymal transition and metastasis of gastric carcinoma cells.

Authors:  Xiao Peng Cai; Liang Dong Chen; Hai Bin Song; Chun Xiao Zhang; Ze Wei Yuan; Zhen Xian Xiang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

3.  Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth.

Authors:  Giovanna Azzarito; Michele Visentin; Brigitte Leeners; Raghvendra K Dubey
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

4.  FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury.

Authors:  Monica Chang-Panesso; Farid F Kadyrov; Matthew Lalli; Haojia Wu; Shiyo Ikeda; Eirini Kefaloyianni; Mai M Abdelmageed; Andreas Herrlich; Akio Kobayashi; Benjamin D Humphreys
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 5.  PLK1, A Potential Target for Cancer Therapy.

Authors:  Zhixian Liu; Qingrong Sun; Xiaosheng Wang
Journal:  Transl Oncol       Date:  2016-11-24       Impact factor: 4.243

6.  The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.

Authors:  Qing Ma; Yanmei Liu; Liang Shang; Jiao Yu; Qiumin Qu
Journal:  Oncol Rep       Date:  2017-10-12       Impact factor: 3.906

7.  Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1.

Authors:  Jiao Yu; Xiaoxia Wang; Yuhua Li; Bin Tang
Journal:  Oncol Rep       Date:  2017-01-30       Impact factor: 3.906

8.  MicroRNA‑320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1.

Authors:  Shiyue Zhao; Yangwei Wang; Yan Lou; Yonggang Wang; Jing Sun; Manyu Luo; Wen Li; Lining Miao
Journal:  Oncol Rep       Date:  2018-07-25       Impact factor: 3.906

9.  Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.

Authors:  Yi Zhou; Zhigang Ji; Weigang Yan; Zhien Zhou; Hanzhong Li; Yu Xiao
Journal:  Oncol Rep       Date:  2017-06-29       Impact factor: 3.906

10.  LncRNA LOC653786 promotes growth of RCC cells via upregulating FOXM1.

Authors:  Fan Yang; Qingjian Wu; Yan Zhang; Haojun Xiong; Xinzhe Li; Bo Li; Wei Xie; Le Zhang; Min Xu; Kebin Zhang; Fengtian He
Journal:  Oncotarget       Date:  2018-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.